Viewing Study NCT03853694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-02-01 @ 12:26 AM
Study NCT ID: NCT03853694
Status: COMPLETED
Last Update Posted: 2022-07-18
First Post: 2018-09-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section
Sponsor: Pacira Pharmaceuticals, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Elective Cesarean Section View
None Pain Management View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bupivacaine View
None EXPAREL View
None analgesic View
None TAP Block View
None C-Section View
None Cesarean Section View
None elective c-section View
None TAP View